A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a…

Overview of attention for article published in Annals of Oncology, February 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 5 X users
patent: 4 patents

facebook: 1 Facebook page
wikipedia: 1 Wikipedia page

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 154,494 followers.

RT @Annals_Oncology: A phase 2, randomised, placebo-controlled trial conducted to evaluate the efficacy & safety of #motolimod https://t.co…

A phase 2, randomised, placebo-controlled trial conducted to evaluate the efficacy & safety of #motolimod https://t.co/3cREVKKCPk #oncology

A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod… https://t.co/YorRrJF7dC

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.